The immediate prospects for the USD rally to extend have ebbed with Powell in the Fed chair, the House tax bill not challenging the modest baseline we have for fiscal stimulus, and wage growth backsliding. But we're not too worried about the broad dollar rolling over given the constructive environment for US growth and continue to hold USD longs vs CHF and JPY.
We retain a modest USD long against the low yielders as the momentum in US growth and growth expectations should allow the dollar to consolidate at worst pending an inflation shock that forces Treasury yields above the annual range highs at 2.50%.
Today’s resilience to what was a disappointing payrolls report, especially on the wage front, is encouraging for the dollar, as is the indifference to a Powell-led Fed.
We are still biased for another leg lower to ideal targets between 1.15 and 1.14, which should complete the phase from the 1.2090 highs. We are then looking for a broader range to develop around 1.1900, but couldn’t rule out a re-test of the 1.21-1.23 key resistance zone in that process.
The EURUSD call spread is a legacy position from before the ECB -we keep this as a portfolio level hedge to US tax reform faltering in Congress as the structure is virtually worthless and so not worth unwinding.
Bought 1.5m USDCHF risk-reversal which is still deemed to bearish (1.01/ 0.97; spot ref: 0.9984) for 24.5bp October 27. Marked at 27.3bp.
Long USDJPY from 113.75 in October end. Stop at 111.50. Marked at +0.46%.
Long a 2m 1.20-1.23 EURUSD call spread. Paid 46bp on September 29th.


Silver Sheds Gains in Gold’s Wake as Bears Probe Key $74.50 Support; Sell-on-Rallies Eyes $70
Spying, Southampton and economic pressure cooker of the ‘richest match in football’
Mega IPOs Like SpaceX and OpenAI Could Reshape S&P 500 and Nasdaq 100 Portfolios in 2026
U.S. Treasury Yields Expected to Decline Amid Cooling Economic Pressures
NHS shakeup: if it sounds like we’ve been here before, it’s because we have
Wall Street Analysts Weigh in on Latest NFP Data
Stock Futures Dip as Investors Await Key Payrolls Data
China's Refining Industry Faces Major Shakeup Amid Challenges
JPMorgan Sees Biotech Sector at Turning Point, Upgrades Top Pharma Stocks
U.S. Banks Report Strong Q4 Profits Amid Investment Banking Surge
US Futures Rise as Investors Eye Earnings, Inflation Data, and Wildfire Impacts 



